The four evidence-based options — NRT, varenicline, bupropion, and cytisine — all beat placebo. Choosing between them is about medical history, cost, and what you have tried before.

Effect size (Cochrane 2023 network meta-analysis)

Roughly ordered:

  1. Varenicline
  2. Combination NRT (patch + short-acting)
  3. Cytisine (comparable to varenicline in the 2024 head-to-head)
  4. Bupropion + NRT combined
  5. Single-form NRT
  6. Bupropion alone
  7. Placebo

The gap between varenicline and single-form NRT is meaningful; the gap between varenicline and combination NRT is small.

Side-effect comparison

Medication Common Serious concerns
Varenicline Vivid dreams, mild nausea Mood changes rare; boxed warning removed 2016
Bupropion Insomnia, dry mouth Seizures (dose-related), contraindicated in seizure/eating disorders
Cytisine GI upset, mild insomnia Very few
NRT Skin irritation, hiccups, mouth soreness Rare; safer than continued nicotine use

Cost comparison (rough US 2026 out of pocket, generic)

Medication Full course
Varenicline (12 wk) $150-400
Bupropion SR (12 wk) $50-150
Cytisine (25 d) Not available in US as FDA-approved
NRT (12 wk combination) $150-300

All four are typically fully covered by ACA-compliant US insurance and by NHS Stop Smoking Services in the UK.

Decision guide

  • First attempt, no contraindications: varenicline (or cytisine where available).
  • Concurrent depression / ADHD: bupropion.
  • Seizure or eating disorder history: avoid bupropion; choose varenicline, cytisine, or NRT.
  • Recent MI / unstable angina: clinician-supervised NRT or varenicline; delay bupropion.
  • Previous failed cold-turkey quit: add a medication.
  • Previous failed NRT quit: try varenicline or cytisine.
  • Previous failed varenicline quit (efficacy): combination NRT or bupropion.

See getting a prescription for how to open the conversation with a clinician.